Silke Gillessen gives a summary of the 2024 Advanced Prostate Cancer Consensus Conference, covering key aspects of the meeting including surgery versus RT, genetic and somatic testing, PSMA imaging, and first-line triplet therapy.
Professor Gillessen serves as the Genitourinary Cancer Systemic Therapy Research Chair at the University of Manchester, and is Head of the Department of Medical Oncology, at the Università della Svizzera Italiana in Lugano, and Director of the Oncology Institute of Southern Switzerland in Bellinzona, Switzerland.